Black Rock Inc. Tango Therapeutics, Inc. Call Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
Others Institutions Holding TNGX
# of Institutions
123Shares Held
97.1MCall Options Held
1.1KPut Options Held
2.7K-
Trv Gp Iv, LLC Boston, MA16.9MShares$114 Million97.21% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA10.7MShares$72.6 Million3.54% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA10.6MShares$71.9 Million1.14% of portfolio
-
Nextech Invest, Ltd. Zurich, V85.53MShares$37.4 Million1.76% of portfolio
-
Nextech Invest Ag5.53MShares$37.4 Million3.19% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $595M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...